Sandia National Laboratories awards equipment contract to Arrayit Corporation

NewsGuard 100/100 Score

Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences and nanotechnology technology leader, announces that on September 11th, 2009 Arrayit delivered its proprietary nanotechnology platform to Sandia National Laboratories in Albuquerque, New Mexico. Sandia Labs, managed by the Lockheed Martin Corporation, works with the Transportation Security Administration (TSA) and the Department of Homeland Security to enhance national security.

Sandia will utilize Arrayit's proprietary nanotechnology manufacturing platform, which empowers researchers to create microarrays, biosensors and "chemical noses" that detect the biological and chemical agents used in lethal terrorist attacks. Arrayit's patented delivery system deposits nanoliter quantities of analytical reagents onto proprietary substrates to create the sophisticated detection devices.

"We are pleased to receive this contract from the prestigious Sandia Labs," states Rene Schena, CEO and co-founder of Arrayit Corp. "We look forward to leveraging our unique and patented nanotechnology capabilities to enhance national safety."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates